SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.
SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.
复制标题
SN79是一种Sigma受体拮抗剂,通过阻断OSMR/GP130信号传导和STAT3磷酸化,减弱了甲基苯丙胺诱导的星形胶质细胞增多症。
DOI:
10.1016/j.expneurol.2014.01.020
复制
发表时间:
2014-04
影响因子:
5.3
通讯作者:
Matsumoto, Rae R.
中科院分区:
文献类型:
--
作者:
Robson, Matthew J.;Turner, Ryan C.;Naser, Zachary J.;McCurdy, Christopher R.;O'Callaghan, James P.;Huber, Jason D.;Matsumoto, Rae R.
Methamphetamine (METH) exposure results in dopaminergic neurotoxicity in striatal regions of the brain, an effect that has been linked to an increased risk of Parkinson's disease. Various aspects of neuroinflammation, including astrogliosis, are believed to be contributory factors in METH neurotoxicity. METH interacts with sigma receptors at physiologically relevant concentrations and treatment with sigma receptor antagonists has been shown to mitigate METH-induced neurotoxicity in rodent models. Whether these compounds alter the responses of glial cells within the central nervous system to METH however has yet to be determined. Therefore, the purpose of the current study was to determine whether the sigma receptor antagonist, SN79, mitigates METH-induced striatal reactive astrogliosis. Male, Swiss Webster mice treated with a neurotoxic regimen of METH exhibited time-dependent increases in striatal gfap mRNA and concomitant increases in GFAP protein, indicative of astrogliosis. This is the first report that similar to other neurotoxicants that induce astrogliosis through the activation of JAK2/STAT3 signaling by stimulating gp-130-linked cytokine signaling resulting from neuroinflammation, METH treatment also increases astrocytic oncostatin m receptor (OSMR) expression and the phosphorylation of STAT3 (Tyr-705) in vivo. Pretreatment with SN79 blocked METH-induced increases in OSMR, STAT3 phosphorylation and astrocyte activation within the striatum. Additionally, METH treatment resulted in striatal cellular degeneration as measured by Fluoro-Jade B, an effect that was mitigated by SN79. The current study provides evidence that sigma receptor antagonists attenuate METH-induced astrocyte activation through a pathway believed to be shared by various neurotoxicants.
登录
查看更多内容
DOI:
10.1126/science.1166127
发表时间:
2009-02-13
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Fontanilla D;Johannessen M;Hajipour AR;Cozzi NV;Jackson MB;Ruoho AE
通讯作者:
Ruoho AE
影响因子:
4.7
作者:
Kaushal, Nidhi;Seminerio, Michael J.;Shaikh, Jamaluddin;Medina, Mark A.;Mesangeau, Christophe;Wilson, Lisa L.;McCurdy, Christopher R.;Matsumoto, Rae R.
通讯作者:
Matsumoto, Rae R.
影响因子:
2.1
作者:
Ajmo, Craig T., Jr.;Vernon, Dionne O. L.;Cuevas, Javier
通讯作者:
Cuevas, Javier
影响因子:
5.3
作者:
Kaushal N;Matsumoto RR
通讯作者:
Matsumoto RR
影响因子:
4.2
作者:
Anderson, KJ;Fugaccia, I;Scheff, SW
通讯作者:
Scheff, SW